FR2321475A1 - Esters d'acides dicarboxyliques asymetriques reactifs et leur utilisation pour l'etude des glucosides tonicardiaques - Google Patents

Esters d'acides dicarboxyliques asymetriques reactifs et leur utilisation pour l'etude des glucosides tonicardiaques

Info

Publication number
FR2321475A1
FR2321475A1 FR7625422A FR7625422A FR2321475A1 FR 2321475 A1 FR2321475 A1 FR 2321475A1 FR 7625422 A FR7625422 A FR 7625422A FR 7625422 A FR7625422 A FR 7625422A FR 2321475 A1 FR2321475 A1 FR 2321475A1
Authority
FR
France
Prior art keywords
tonicardiac
asymetric
glucosides
reagent
study
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7625422A
Other languages
English (en)
French (fr)
Other versions
FR2321475B1 (US08080257-20111220-C00005.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of FR2321475A1 publication Critical patent/FR2321475A1/fr
Application granted granted Critical
Publication of FR2321475B1 publication Critical patent/FR2321475B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/822Identified hapten
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/823Immunogenic carrier or carrier per se

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7625422A 1975-08-20 1976-08-20 Esters d'acides dicarboxyliques asymetriques reactifs et leur utilisation pour l'etude des glucosides tonicardiaques Granted FR2321475A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2537129A DE2537129C3 (de) 1975-08-20 1975-08-20 Reaktive unsymmetrische, einen Digoxin- bzw. Digitoxinrest enthaltende Dicarbonsäureester, Verfahren zu deren Herstellung sowie ihre Verwendung zur Herstellung von Testreagentien

Publications (2)

Publication Number Publication Date
FR2321475A1 true FR2321475A1 (fr) 1977-03-18
FR2321475B1 FR2321475B1 (US08080257-20111220-C00005.png) 1982-06-18

Family

ID=5954435

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7625422A Granted FR2321475A1 (fr) 1975-08-20 1976-08-20 Esters d'acides dicarboxyliques asymetriques reactifs et leur utilisation pour l'etude des glucosides tonicardiaques

Country Status (9)

Country Link
US (3) US4133949A (US08080257-20111220-C00005.png)
JP (1) JPS5855160B2 (US08080257-20111220-C00005.png)
AT (1) AT350040B (US08080257-20111220-C00005.png)
CH (2) CH630613A5 (US08080257-20111220-C00005.png)
DE (1) DE2537129C3 (US08080257-20111220-C00005.png)
FR (1) FR2321475A1 (US08080257-20111220-C00005.png)
GB (2) GB1518055A (US08080257-20111220-C00005.png)
IT (1) IT1064727B (US08080257-20111220-C00005.png)
NL (1) NL171989C (US08080257-20111220-C00005.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1107772B (it) * 1977-08-22 1985-11-25 Cancer Res Inst Royal Procedimento per la produzione di complessi macromolecolari prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
US4443621A (en) * 1983-03-14 1984-04-17 Pfizer Inc. p-Nitrophenyl 3-bromo-2,2-diethoxy-propionate and synthetic utility therefor
FR2574075B1 (fr) * 1984-12-04 1987-09-18 Poudres & Explosifs Ste Nale Procede de synthese d'esters actifs d'acides carboxyliques, nouveaux carbonates alpha-halogenes utiles pour cette synthese et leur mode d'obtention

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1668723A1 (de) * 1966-09-16 1971-04-08 Toyo Jozo Kk Verfahren zum Herstellen von Verbindungen mit Saeureamid-Bindung
US3963697A (en) * 1974-08-29 1976-06-15 Curtis Nuclear Corporation Labelled cardiotonic glycosides for use in radioimmunoassay

Also Published As

Publication number Publication date
NL171989C (nl) 1983-06-16
GB1518054A (en) 1978-07-19
US4436828A (en) 1984-03-13
AT350040B (de) 1979-05-10
GB1518055A (en) 1978-07-19
DE2537129C3 (de) 1978-05-03
FR2321475B1 (US08080257-20111220-C00005.png) 1982-06-18
US4282151A (en) 1981-08-04
NL171989B (nl) 1983-01-17
JPS5225722A (en) 1977-02-25
ATA433376A (de) 1978-10-15
DE2537129B2 (de) 1977-09-29
US4133949A (en) 1979-01-09
IT1064727B (it) 1985-02-25
DE2537129A1 (de) 1977-02-24
JPS5855160B2 (ja) 1983-12-08
CH630613A5 (de) 1982-06-30
NL7609014A (nl) 1977-02-22
CH637659A5 (de) 1983-08-15

Similar Documents

Publication Publication Date Title
BE842329A (fr) Nouveaux esters-17b d'oestradiol et compositions therapeutiques renfermant des esters-17b d'oestradiol
BE846400A (fr) Chelates d'organotitanates et leur utilisation
JPS5248648A (en) 22higher alkyll33hydroxyy 1*44naphthoquinone carboxylic acid ester containing composition and use thereof*
FR2351135A1 (fr) Procede de preparation de copolymeres d'acides acrylique et methacrylique et d'esters acryliques et methacryliques
PT67352A (fr) Procedes pour la preparation d'acides thiazolidinacarboxidiques et acides en rapportes
BE856278A (fr) Nouveaux derives d'acide penicillanique et leur utilisation therapeutique
BE816206A (fr) Esters mixtes d'acides polyfonctionnels satures
FR2318645A1 (fr) 3-oximes d'esters de d-17a-ethynyl-19-nortestosterone et leur procede de preparation
BE837665A (fr) Catalyseur contenant du rhodium et son utilisation dans la preparation de 1' -6-desoxy-5-tetracycline
MY7800089A (en) Preparation of acrylic acid and methacrylic acid
BE787759A (fr) Thioloesters d'acides guanidine-organiques et leur preparation
FR2326425A1 (fr) Chelates d'organotitanates et leur utilisation
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
FR2330398A1 (fr) Esters d'acides 3-aminomethylene-6,7-dimethoxy-2 -methyl-4 -oxo-1,2,3,4- tetrahydro-1- quinoleine carboxyliques et intermediaires y conduisant
FR2321475A1 (fr) Esters d'acides dicarboxyliques asymetriques reactifs et leur utilisation pour l'etude des glucosides tonicardiaques
ZA765392B (en) Novel benzimidoylthionothiolphosphoric acid esters and their use as insecticides and acaricides
FR2337139A1 (fr) Esters d'acides mercaptodicarboxyliques organo-stanniques et compositions en renfermant
BE846040A (fr) Esters d'acides furanose-o-pyridylcarboxyliques
ZA764988B (en) Vinylthionophosphoric acid esters and their use as insecticides and acaricides
FR2332979A1 (fr) Halogenures d'acides sulfamiques et leur preparation
BE756232A (fr) Anilides de l'acide 3-acyl-alpha-resorcylique et leur preparation
FR2336389A1 (fr) Esters d'acides thiol-carboxyliques et leur preparation
BE809633A (fr) Nouveaux esters et esteramides d'acides 0-triazolylthionophosphoriques (phosphoniques)
BE750165A (fr) Amides et esters de l'acide 1-hydroxy-benzimidazole-2- carboxylique et leur preparation
BE845201A (fr) Epreuve pour determiner la comptabilite et le groupe des globules sanguins